Kiora Pharmaceuticals reported earnings of -$ 0.28 per KPRX share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.38 |
| Earnings Per Share (Surprise) | -$ 0.28 (+$ 0.10) |
| Last Year's EPS | -$ 0.66 |
| EPS YoY Change |
Out of the last 56 earnings reporting periods, Kiora Pharmaceuticals beat analysts’ expectations 26 times and fell short of expectations 16 time(s). Kiora Pharmaceuticals reported earnings per share of -$ 0.28 in the last report surpassing an estimated EPS of -$ 0.38 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.38 | -$ 0.28 | $ 0.01 | |
| Aug 7, 2026 | -$ 0.47 | -$ 0.34 | -$ 0.54 | |
| May 8, 2026 | -$ 0.71 | -$ 0.58 | -$ 0.52 | |
| Mar 25, 2026 | -$ 0.67 | -$ 1.60 | -$ 1.04 | |
| Nov 7, 2025 | -$ 0.72 | $ 0.01 | -$ 0.81 | |
| Aug 8, 2025 | -$ 0.58 | -$ 0.54 | -$ 0.53 | |
| May 9, 2025 | -$ 0.77 | -$ 0.52 | $ 3.42 | |
| Mar 25, 2025 | -$ 0.64 | -$ 1.04 | -$ 0.47 | |
| Nov 8, 2024 | -$ 0.90 | -$ 0.81 | -$ 0.47 | |
| Aug 9, 2024 | -$ 0.95 | -$ 0.53 | -$ 8.01 | |
| May 10, 2024 | $ 5.58 | $ 3.42 | -$ 7.11 | |
| Mar 28, 2024 | -$ 0.42 | -$ 0.47 | -$ 1.00 | |
| Mar 25, 2024 | -$ 0.42 | -$ 0.47 | -$ 1.76 | |
| Nov 9, 2023 | -$ 2.70 | -$ 8.01 | -$ 7.70 | |
| Aug 8, 2023 | -$ 4.59 | -$ 7.11 | -$ 64.81 | |
| May 9, 2023 | -$ 1.68 | -$ 1.00 | -$ 10.80 | |
| Mar 23, 2023 | -$ 2.46 | -$ 1.76 | -$ 280.83 | |
| Nov 9, 2022 | -$ 3.83 | -$ 7.70 | -$ 104.41 | |
| Aug 12, 2022 | -$ 72.01 | -$ 64.81 | -$ 14.00 | |
| Jul 8, 2022 | -$ 9.20 | -$ 10.80 | -$ 14.80 |
Kiora Pharmaceuticals’s stock was trading at $ 1.35 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, KPRX’s price decreased to $ 1.23 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.28 | $ 1.35 | $ 1.23 | |
| Aug 7, 2026 | -$ 0.34 | $ 2.56 | $ 2.58 | |
| May 8, 2026 | -$ 0.58 | $ 2.45 | $ 2.41 | |
| Mar 25, 2026 | -$ 1.60 | $ 2.06 | $ 1.97 | |
| Nov 7, 2025 | $ 0.01 | $ 2.32 | $ 2.33 | |
| Aug 8, 2025 | -$ 0.54 | $ 2.39 | $ 2.45 | |
| May 9, 2025 | -$ 0.52 | $ 3.12 | $ 3.19 | |
| Mar 25, 2025 | -$ 1.04 | $ 3.20 | $ 2.99 | |
| Nov 8, 2024 | -$ 0.81 | $ 3.57 | $ 3.74 | |
| Aug 9, 2024 | -$ 0.53 | $ 3.26 | $ 3.24 | |
| May 10, 2024 | $ 3.42 | $ 4.37 | $ 4.59 | |
| Mar 28, 2024 | -$ 0.47 | $ 5.55 | $ 5.40 | |
| Mar 25, 2024 | -$ 0.47 | $ 5.40 | $ 5.49 | |
| Nov 9, 2023 | -$ 8.01 | $ 5.65 | $ 5.70 | |
| Aug 8, 2023 | -$ 7.11 | $ 5.13 | $ 5.00 | |
| May 9, 2023 | -$ 1.00 | $ 22.77 | $ 22.95 | |
| Mar 23, 2023 | -$ 1.76 | $ 32.67 | $ 29.88 | |
| Nov 9, 2022 | -$ 7.70 | $ 56.25 | $ 54.81 | |
| Aug 12, 2022 | -$ 64.81 | $ 65.52 | $ 55.80 | |
| Jul 8, 2022 | -$ 10.80 | $ 169.16 | $ 160.63 |
Kiora Pharmaceuticals released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Kiora Pharmaceuticals beat analysts’ expectations during the last earnings period by
